Add-on metformin promising in ER-positive endometrial cancer
UC Cancer Center expert comments featured in MedPage Today article
The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor (ER)-positive endometrial cancer.
All 25 patients in the RESOLVE study, led by Dana-Farber Cancer Institute, received metformin in addition to the drugs letrozole and abemaciclib.
At a median follow-up of 17 months, three patients had a complete response to the therapy, five had a partial response and 16 had stable disease. Median progression free survival was beyond 19.3 months, with no patients stopping the therapy due to toxicities.
Jackson, MD, noted multiple studies have suggested metformin can have a positive effect on progression free survival for this subset of patients.
While not effective to treat specific mutations, "metformin seems cost effective and has minimal side effects, and is probably a great option," said Jackson, a Cancer Center physician-researcher and associate professor, division chief and vice chair in the UC College of Medicine’s Department of Obstetrics & Gynecology.
Read the MedPage Today article.
Featured photo at top of hands holding a vial of metformin. Photo/Tashatuvango/iStock Photo.
Related Stories
These teeny spiders are social media stars
August 28, 2026
The New York Times turned to a University of Cincinnati professor to explain the appeal of jumping spiders on social media.
An internal divide among unions on AI impacts the Wisconsin gubernatorial race
August 28, 2026
Anne Lofaso, a professor in the Donald P. Klekamp College of Law at UC, spoke with Wisconsin Public Radio, about the schism among unions over AI and whether it is a plus, a negative, or somewhere in between when looking at job creation.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.